HRT Financial’s sudden $0.09 buy‑the‑dip of 1.5m WORK Medical shares shows a cautious, short‑term spec strategy amid a highly volatile, low‑liquidity medical‑tech niche—highlighting both rebound potential and high risk.
Insider confidence in WORK Medical Technology: HRT Financial LP holds $24.8k of stock at $0.11/share. Learn how insider stakes can signal upside amid a sharp 91% price drop.